Virtus Biotech Clinical TriaBBCETF
13F holders, Q3 2024 (September 30)13holders −1
1new positions
2sold out
1famous investor
$27.94avg. 13F price*
At the end of Q3 2024, 13 institutions reported holding Virtus Biotech Clinical Tria (BBC) in their 13F filings, down 1 from Q2 2024. 1 opened new positions and 2 sold out. The largest holders were Susquehanna International Group, LLP ($1.3M), Citadel Advisors ($968K) and Morgan Stanley ($368K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Virtus Biotech Clinical Tria
- Filed as
- ETFIS SER TR I (Q3 2024)
- CUSIP
- 26923G301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 2 | $2K |
All 13F filers, Q2 2024 → Q3 2024: 12,706 shares bought and 13,772 shares sold, net −1,066 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Susquehanna International Group, LLP | 0.00% | Add +37.5% | 46,109 | $1.3M |
| Citadel Advisors | 0.00% | Reduce -13.6% | 34,631 | $968K |
| Morgan Stanley | 0.00% | Reduce -38.3% | 13,153 | $368K |
| LPL Financial LLC | 0.00% | Add +0.8% | 12,813 | $358K |
| US Bancorp \de | 0.00% | No change | 1,000 | $28K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 838 | $23K |
| Dynamic Wealth Strategies, LLC | 0.02% | No change | 802 | $22K |
| Osaic Holdings, Inc. | 0.00% | No change | 447 | $12K |
| Harbour Investments, Inc. | 0.00% | Reduce -25.2% | 232 | $6K |
| Baldwin Wealth Partners LLC | 0.00% | No change | 100 | $3K |
| Venturi Wealth Management, LLC | 0.00% | New | 44 | $1K |
| Allworth Financial LP | 0.00% | No change | 10 | $280 |
| NewEdge Advisors, LLC | 0.00% | No change | 5 | $140 |
"% of holder's portfolio" is BBC's weight in each manager's 13F, not the share of Virtus Biotech Clinical Tria the manager owns.